Comment on “Massive idiopathic pericardial effusion in a pediatric patient responsive to interleukin-1 receptor antagonist: Unveiling an undercover hyperinflammation?”
Author:
Open Access
- 8 September 2026
- journal article
- Published by Wolters Kluwer Health in Annals of Pediatric Cardiology
- Vol. 19 (5) , 619-620
Abstract
Was not provided for this article.Keywords
This publication has 5 references indexed in Scilit:
- Myocarditis and pericarditis in focus: A critical appraisal of the 2025 ESC vs ACC position statements from the Italian society of cardiology working group on cardiomyopathies and pericardial diseasesTrends in Cardiovascular Medicine, 2026
- Massive idiopathic pericardial effusion in a pediatric patient responsive to interleukin-1 receptor antagonist: Unveiling an undercover hyperinflammation?Annals of Pediatric Cardiology, 2026
- Efficacy of colchicine in addition to anakinra in patients with recurrent pericarditisOpen Heart, 2024
- Pediatric Recurrent Pericarditis: Appropriateness of the Standard of Care and Response to IL-1 BlockadeThe Journal of Pediatrics, 2022
- Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?Journal of Autoimmunity, 2020